Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,18 USD | +0,66% | +17,09% | +184,21% |
15/05 | ARCUTIS BIOTHERAPEUTICS, INC. : Needham & Co. herhaalt koopadvies | ZM |
15/05 | ARCUTIS BIOTHERAPEUTICS, INC. : Mizuho Securities bevestigt koopadvies | ZM |
Omzet 2024 * | 160 mln. 147 mln. | Omzet 2025 * | 237 mln. 218 mln. | Marktkapitalisatie | 1,07 mld. 979 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -189 mln. -174 mln. | Nettowinst (verlies) 2025 * | -142 mln. -131 mln. | EV/omzet 2024 * | 5,21 x |
Nettoliquiditeiten 2024 * | 231 mln. 213 mln. | Nettoliquiditeiten 2025 * | 228 mln. 210 mln. | EV/omzet 2025 * | 3,53 x |
K/w-verhouding 2024 * |
-5,44
x | K/w-verhouding 2025 * |
-7,85
x | Werknemers | 296 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,89% |
Recentste transcriptie over Arcutis Biotherapeutics, Inc.
1 dag | +0,66% | ||
1 week | +17,09% | ||
Lopende maand | +10,34% | ||
1 maand | +0,88% | ||
3 maanden | -1,29% | ||
6 maanden | +350,00% | ||
Lopend jaar | +184,21% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 55 | 01-01-16 |
Rajvir Madan
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-21 |
Jay Ramsinghani
COO | Chief Operating Officer | - | 27-05-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Patrick Heron
CHM | Chairman | 53 | 01-04-16 |
Founder | 69 | 01-06-16 | |
Keith Leonard
BRD | Director/Board Member | 62 | 02-09-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.08% | 0 M€ | 0,00% | - | |
0.06% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-05-24 | 9,2 | +0,88% | 3 450 543 |
16-05-24 | 9,12 | -1,30% | 4 310 073 |
15-05-24 | 9,24 | +13,65% | 13 896 318 |
14-05-24 | 8,13 | +1,75% | 4 658 048 |
13-05-24 | 7,99 | +1,91% | 2 339 107 |
uitgestelde koers Nasdaq, 17 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+184,21% | 1,07 mld. | |
+9,42% | 115 mld. | |
+11,84% | 106 mld. | |
-1,05% | 21,96 mld. | |
-14,15% | 21,87 mld. | |
-5,29% | 19,21 mld. | |
-4,16% | 18,08 mld. | |
-38,29% | 17,71 mld. | |
+7,99% | 14,32 mld. | |
+36,24% | 12,42 mld. |